Antigua and Barbuda
Tuberculosis profile
Population  2013 <1 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 1.4 (1.2–1.5)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.018 (<0.01–0.031) 20 (9.6–35)
Incidence  (includes HIV+TB) 0.012 (0.01–0.013) 13 (11–14)
Incidence (HIV+TB only)        
Case detection, all forms (%) 87 (77–99)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.3–3.1) 14 (4.7–22)
MDR-TB cases among notified pulmonary
TB cases
0 (0–0) 0 (0–0)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 1   0
Pulmonary, clinically diagnosed 6   0
Extrapulmonary 2   1
       
Total new and relapse 10    
Previously treated, excluding relapses 1    
Total cases notified 11    
Among 10 new and relapse cases:
1 (10%) cases aged under 15 years; male:female ratio: 9.0
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 0 (0%) 0 (0%) 0
Laboratory-confirmed RR-/MDR-TB cases     0
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status 10 (91)
HIV-positive TB patients 5 (50)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 5 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 5 (100)
HIV-positive people screened for TB 125  
HIV-positive people provided with IPT 5  
Treatment success rate (%)
New cases registered in 2012 50
Previously treated cases registered in 2012  
HIV-positive TB cases, all types, registered in 2012 0
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, outside
country
Financing TB control 2014  
National TB programme budget (US$ millions) <1
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-09-02 Data: www.who.int/tb/data